Sino Biopharmaceutical Ltd
HKEX:1177
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.34
4.15
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Sino Biopharmaceutical Ltd
Sino Biopharmaceutical Ltd
Operating Income
Sino Biopharmaceutical Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Operating Income
¥6.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
6%
|
CAGR 10-Years
15%
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Operating Income
HK$2.7B
|
CAGR 3-Years
9%
|
CAGR 5-Years
17%
|
CAGR 10-Years
26%
|
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Operating Income
¥3.7B
|
CAGR 3-Years
39%
|
CAGR 5-Years
33%
|
CAGR 10-Years
13%
|
|
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
Operating Income
¥993.8m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
9%
|
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Operating Income
HK$19.6B
|
CAGR 3-Years
23%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
H
|
HUTCHMED (China) Ltd
HKEX:13
|
Operating Income
-$120.8m
|
CAGR 3-Years
23%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-77%
|
See Also
What is Sino Biopharmaceutical Ltd's Operating Income?
Operating Income
6.4B
CNY
Based on the financial report for Jun 30, 2024, Sino Biopharmaceutical Ltd's Operating Income amounts to 6.4B CNY.
What is Sino Biopharmaceutical Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
15%
Over the last year, the Operating Income growth was 8%. The average annual Operating Income growth rates for Sino Biopharmaceutical Ltd have been 8% over the past three years , 6% over the past five years , and 15% over the past ten years .
You don't have any saved screeners yet
